Project
Illumina Body Map 2: averaged replicates
Navigation
Downloads
Results for HNF4A
Z-value: 4.86
Motif logo
Transcription factors associated with HNF4A
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
HNF4A
|
ENSG00000101076.12 | hepatocyte nuclear factor 4 alpha |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| HNF4A | hg19_v2_chr20_+_42984330_42984445 | 0.83 | 2.9e-09 | Click! |
Activity profile of HNF4A motif
Sorted Z-values of HNF4A motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr10_+_96698406 | 28.68 |
ENST00000260682.6
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9 |
| chr17_+_4675175 | 24.03 |
ENST00000270560.3
|
TM4SF5
|
transmembrane 4 L six family member 5 |
| chr10_+_96522361 | 23.86 |
ENST00000371321.3
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19 |
| chr10_-_96829246 | 23.72 |
ENST00000371270.3
ENST00000535898.1 ENST00000539050.1 |
CYP2C8
|
cytochrome P450, family 2, subfamily C, polypeptide 8 |
| chr10_-_129691195 | 23.41 |
ENST00000368671.3
|
CLRN3
|
clarin 3 |
| chr5_-_35048047 | 21.66 |
ENST00000231420.6
|
AGXT2
|
alanine--glyoxylate aminotransferase 2 |
| chr6_+_30130969 | 21.22 |
ENST00000376694.4
|
TRIM15
|
tripartite motif containing 15 |
| chr3_-_42917363 | 20.50 |
ENST00000437102.1
|
CYP8B1
|
cytochrome P450, family 8, subfamily B, polypeptide 1 |
| chr20_+_56136136 | 20.39 |
ENST00000319441.4
ENST00000543666.1 |
PCK1
|
phosphoenolpyruvate carboxykinase 1 (soluble) |
| chr11_-_116694009 | 20.31 |
ENST00000357780.3
|
APOA4
|
apolipoprotein A-IV |
| chr9_+_139839711 | 19.68 |
ENST00000224181.3
|
C8G
|
complement component 8, gamma polypeptide |
| chr17_+_41052808 | 18.58 |
ENST00000592383.1
ENST00000253801.2 ENST00000585489.1 |
G6PC
|
glucose-6-phosphatase, catalytic subunit |
| chr3_-_120400960 | 18.25 |
ENST00000476082.2
|
HGD
|
homogentisate 1,2-dioxygenase |
| chr19_+_45449266 | 18.11 |
ENST00000592257.1
|
APOC2
|
apolipoprotein C-II |
| chr9_+_139839686 | 17.98 |
ENST00000371634.2
|
C8G
|
complement component 8, gamma polypeptide |
| chr20_-_7921090 | 17.73 |
ENST00000378789.3
|
HAO1
|
hydroxyacid oxidase (glycolate oxidase) 1 |
| chr6_+_131148538 | 17.70 |
ENST00000541421.2
|
SMLR1
|
small leucine-rich protein 1 |
| chr19_+_45449228 | 17.59 |
ENST00000252490.4
|
APOC2
|
apolipoprotein C-II |
| chr10_+_96443378 | 17.55 |
ENST00000285979.6
|
CYP2C18
|
cytochrome P450, family 2, subfamily C, polypeptide 18 |
| chr6_+_43265992 | 17.39 |
ENST00000449231.1
ENST00000372589.3 ENST00000372585.5 |
SLC22A7
|
solute carrier family 22 (organic anion transporter), member 7 |
| chr19_+_45449301 | 17.24 |
ENST00000591597.1
|
APOC2
|
apolipoprotein C-II |
| chr1_-_161193349 | 16.74 |
ENST00000469730.2
ENST00000463273.1 ENST00000464492.1 ENST00000367990.3 ENST00000470459.2 ENST00000468465.1 ENST00000463812.1 |
APOA2
|
apolipoprotein A-II |
| chr12_+_56075330 | 16.60 |
ENST00000394252.3
|
METTL7B
|
methyltransferase like 7B |
| chr1_+_145727681 | 16.29 |
ENST00000417171.1
ENST00000451928.2 |
PDZK1
|
PDZ domain containing 1 |
| chr17_+_27369918 | 16.00 |
ENST00000323372.4
|
PIPOX
|
pipecolic acid oxidase |
| chr1_-_155270770 | 15.91 |
ENST00000392414.3
|
PKLR
|
pyruvate kinase, liver and RBC |
| chr10_+_96443204 | 15.27 |
ENST00000339022.5
|
CYP2C18
|
cytochrome P450, family 2, subfamily C, polypeptide 18 |
| chr1_-_177939041 | 15.02 |
ENST00000308284.6
|
SEC16B
|
SEC16 homolog B (S. cerevisiae) |
| chr6_+_31949801 | 14.95 |
ENST00000428956.2
ENST00000498271.1 |
C4A
|
complement component 4A (Rodgers blood group) |
| chr6_+_31982539 | 14.59 |
ENST00000435363.2
ENST00000425700.2 |
C4B
|
complement component 4B (Chido blood group) |
| chr17_-_36105009 | 14.49 |
ENST00000560016.1
ENST00000427275.2 ENST00000561193.1 |
HNF1B
|
HNF1 homeobox B |
| chr1_-_155271213 | 14.10 |
ENST00000342741.4
|
PKLR
|
pyruvate kinase, liver and RBC |
| chr3_-_194072019 | 13.70 |
ENST00000429275.1
ENST00000323830.3 |
CPN2
|
carboxypeptidase N, polypeptide 2 |
| chr1_+_196857144 | 13.58 |
ENST00000367416.2
ENST00000251424.4 ENST00000367418.2 |
CFHR4
|
complement factor H-related 4 |
| chr6_+_31950150 | 13.29 |
ENST00000537134.1
|
C4A
|
complement component 4A (Rodgers blood group) |
| chr3_+_46538981 | 13.15 |
ENST00000296142.3
|
RTP3
|
receptor (chemosensory) transporter protein 3 |
| chr2_-_21266935 | 13.02 |
ENST00000233242.1
|
APOB
|
apolipoprotein B |
| chrX_+_38211777 | 12.82 |
ENST00000039007.4
|
OTC
|
ornithine carbamoyltransferase |
| chr17_-_7082668 | 12.05 |
ENST00000573083.1
ENST00000574388.1 |
ASGR1
|
asialoglycoprotein receptor 1 |
| chr19_-_39303576 | 11.99 |
ENST00000594209.1
|
LGALS4
|
lectin, galactoside-binding, soluble, 4 |
| chr12_-_21757774 | 11.95 |
ENST00000261195.2
|
GYS2
|
glycogen synthase 2 (liver) |
| chr17_-_7082861 | 11.67 |
ENST00000269299.3
|
ASGR1
|
asialoglycoprotein receptor 1 |
| chr20_-_7238861 | 11.41 |
ENST00000428954.1
|
RP11-19D2.1
|
RP11-19D2.1 |
| chr1_-_177939348 | 11.31 |
ENST00000464631.2
|
SEC16B
|
SEC16 homolog B (S. cerevisiae) |
| chr6_-_86099898 | 11.04 |
ENST00000455071.1
|
RP11-30P6.6
|
RP11-30P6.6 |
| chr7_+_45927956 | 10.98 |
ENST00000275525.3
ENST00000457280.1 |
IGFBP1
|
insulin-like growth factor binding protein 1 |
| chr16_-_16317321 | 10.93 |
ENST00000205557.7
ENST00000575728.1 |
ABCC6
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 6 |
| chr1_-_161207875 | 10.60 |
ENST00000512372.1
ENST00000437437.2 ENST00000442691.2 ENST00000412844.2 ENST00000428574.2 ENST00000505005.1 ENST00000508740.1 ENST00000508387.1 ENST00000504010.1 ENST00000511676.1 ENST00000502985.1 ENST00000367981.3 ENST00000515621.1 ENST00000511944.1 ENST00000511748.1 ENST00000367984.4 ENST00000367985.3 |
NR1I3
|
nuclear receptor subfamily 1, group I, member 3 |
| chr19_+_41594377 | 10.45 |
ENST00000330436.3
|
CYP2A13
|
cytochrome P450, family 2, subfamily A, polypeptide 13 |
| chr22_-_42526802 | 10.31 |
ENST00000359033.4
ENST00000389970.3 ENST00000360608.5 |
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6 |
| chr19_+_45116921 | 10.23 |
ENST00000402988.1
|
IGSF23
|
immunoglobulin superfamily, member 23 |
| chr12_+_121416489 | 10.18 |
ENST00000541395.1
ENST00000544413.1 |
HNF1A
|
HNF1 homeobox A |
| chr12_+_109273806 | 10.09 |
ENST00000228476.3
ENST00000547768.1 |
DAO
|
D-amino-acid oxidase |
| chr6_+_43266063 | 9.95 |
ENST00000372574.3
|
SLC22A7
|
solute carrier family 22 (organic anion transporter), member 7 |
| chr7_+_45928079 | 9.83 |
ENST00000468955.1
|
IGFBP1
|
insulin-like growth factor binding protein 1 |
| chr11_-_62997124 | 9.79 |
ENST00000306494.6
|
SLC22A25
|
solute carrier family 22, member 25 |
| chr19_-_36304201 | 9.79 |
ENST00000301175.3
|
PRODH2
|
proline dehydrogenase (oxidase) 2 |
| chr16_+_8768422 | 9.71 |
ENST00000268251.8
ENST00000564714.1 |
ABAT
|
4-aminobutyrate aminotransferase |
| chr17_+_1646130 | 9.55 |
ENST00000453066.1
ENST00000324015.3 ENST00000450523.2 ENST00000453723.1 ENST00000382061.4 |
SERPINF2
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2 |
| chr9_-_136605042 | 9.47 |
ENST00000371872.4
ENST00000298628.5 ENST00000422262.2 |
SARDH
|
sarcosine dehydrogenase |
| chr2_+_44502630 | 9.34 |
ENST00000410056.3
ENST00000409741.1 ENST00000409229.3 |
SLC3A1
|
solute carrier family 3 (amino acid transporter heavy chain), member 1 |
| chr19_+_7660716 | 9.33 |
ENST00000160298.4
ENST00000446248.2 |
CAMSAP3
|
calmodulin regulated spectrin-associated protein family, member 3 |
| chr11_+_27076764 | 8.74 |
ENST00000525090.1
|
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
| chr1_+_6508100 | 8.56 |
ENST00000461727.1
|
ESPN
|
espin |
| chr5_+_176811431 | 8.48 |
ENST00000512593.1
ENST00000324417.5 |
SLC34A1
|
solute carrier family 34 (type II sodium/phosphate contransporter), member 1 |
| chr7_-_15601595 | 8.47 |
ENST00000342526.3
|
AGMO
|
alkylglycerol monooxygenase |
| chr5_-_42812143 | 8.40 |
ENST00000514985.1
|
SEPP1
|
selenoprotein P, plasma, 1 |
| chr1_-_197036364 | 8.28 |
ENST00000367412.1
|
F13B
|
coagulation factor XIII, B polypeptide |
| chr1_-_60392452 | 8.21 |
ENST00000371204.3
|
CYP2J2
|
cytochrome P450, family 2, subfamily J, polypeptide 2 |
| chr1_-_161208013 | 8.20 |
ENST00000515452.1
ENST00000367983.4 |
NR1I3
|
nuclear receptor subfamily 1, group I, member 3 |
| chr5_-_42811986 | 8.19 |
ENST00000511224.1
ENST00000507920.1 ENST00000510965.1 |
SEPP1
|
selenoprotein P, plasma, 1 |
| chr17_+_77704681 | 8.10 |
ENST00000328313.5
|
ENPP7
|
ectonucleotide pyrophosphatase/phosphodiesterase 7 |
| chr3_-_53878644 | 8.08 |
ENST00000481668.1
ENST00000467802.1 |
CHDH
|
choline dehydrogenase |
| chr16_+_29690358 | 7.99 |
ENST00000395384.4
ENST00000562473.1 |
QPRT
|
quinolinate phosphoribosyltransferase |
| chr2_-_21266816 | 7.93 |
ENST00000399256.4
|
APOB
|
apolipoprotein B |
| chr13_+_113777105 | 7.79 |
ENST00000409306.1
ENST00000375551.3 ENST00000375559.3 |
F10
|
coagulation factor X |
| chr1_-_161207953 | 7.67 |
ENST00000367982.4
|
NR1I3
|
nuclear receptor subfamily 1, group I, member 3 |
| chr3_-_187009798 | 7.50 |
ENST00000337774.5
|
MASP1
|
mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) |
| chr3_+_46919235 | 7.47 |
ENST00000449590.1
|
PTH1R
|
parathyroid hormone 1 receptor |
| chr2_-_28113217 | 7.46 |
ENST00000444339.2
|
RBKS
|
ribokinase |
| chr6_+_30131318 | 7.36 |
ENST00000376688.1
|
TRIM15
|
tripartite motif containing 15 |
| chr11_+_63137251 | 7.24 |
ENST00000310969.4
ENST00000279178.3 |
SLC22A9
|
solute carrier family 22 (organic anion transporter), member 9 |
| chr3_-_187009646 | 6.50 |
ENST00000296280.6
ENST00000392470.2 ENST00000169293.6 ENST00000439271.1 ENST00000392472.2 ENST00000392475.2 |
MASP1
|
mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) |
| chr17_+_4692230 | 6.38 |
ENST00000331264.7
|
GLTPD2
|
glycolipid transfer protein domain containing 2 |
| chr2_-_31637560 | 6.28 |
ENST00000379416.3
|
XDH
|
xanthine dehydrogenase |
| chr1_-_15911510 | 6.20 |
ENST00000375826.3
|
AGMAT
|
agmatine ureohydrolase (agmatinase) |
| chrX_+_66764375 | 6.08 |
ENST00000374690.3
|
AR
|
androgen receptor |
| chr17_-_44896047 | 5.83 |
ENST00000225512.5
|
WNT3
|
wingless-type MMTV integration site family, member 3 |
| chr1_+_199996733 | 5.76 |
ENST00000236914.3
|
NR5A2
|
nuclear receptor subfamily 5, group A, member 2 |
| chr4_-_88244049 | 5.74 |
ENST00000328546.4
|
HSD17B13
|
hydroxysteroid (17-beta) dehydrogenase 13 |
| chr12_+_121416340 | 5.72 |
ENST00000257555.6
ENST00000400024.2 |
HNF1A
|
HNF1 homeobox A |
| chr1_-_161207986 | 5.68 |
ENST00000506209.1
ENST00000367980.2 |
NR1I3
|
nuclear receptor subfamily 1, group I, member 3 |
| chr2_+_44502597 | 5.63 |
ENST00000260649.6
ENST00000409387.1 |
SLC3A1
|
solute carrier family 3 (amino acid transporter heavy chain), member 1 |
| chr14_+_38677123 | 5.57 |
ENST00000267377.2
|
SSTR1
|
somatostatin receptor 1 |
| chr1_+_199996702 | 5.37 |
ENST00000367362.3
|
NR5A2
|
nuclear receptor subfamily 5, group A, member 2 |
| chr2_-_43019698 | 5.33 |
ENST00000431905.1
ENST00000294973.6 |
HAAO
|
3-hydroxyanthranilate 3,4-dioxygenase |
| chr4_-_88244010 | 5.30 |
ENST00000302219.6
|
HSD17B13
|
hydroxysteroid (17-beta) dehydrogenase 13 |
| chr16_-_87970122 | 5.29 |
ENST00000309893.2
|
CA5A
|
carbonic anhydrase VA, mitochondrial |
| chr22_+_25003626 | 5.27 |
ENST00000451366.1
ENST00000406383.2 ENST00000428855.1 |
GGT1
|
gamma-glutamyltransferase 1 |
| chr3_-_124653579 | 5.18 |
ENST00000478191.1
ENST00000311075.3 |
MUC13
|
mucin 13, cell surface associated |
| chr6_+_43028182 | 5.15 |
ENST00000394058.1
|
KLC4
|
kinesin light chain 4 |
| chr1_+_94883991 | 5.11 |
ENST00000370214.4
|
ABCD3
|
ATP-binding cassette, sub-family D (ALD), member 3 |
| chr11_+_74870818 | 4.97 |
ENST00000525845.1
ENST00000534186.1 ENST00000428359.2 |
SLCO2B1
|
solute carrier organic anion transporter family, member 2B1 |
| chr1_+_78511586 | 4.77 |
ENST00000370759.3
|
GIPC2
|
GIPC PDZ domain containing family, member 2 |
| chr1_+_94883931 | 4.67 |
ENST00000394233.2
ENST00000454898.2 ENST00000536817.1 |
ABCD3
|
ATP-binding cassette, sub-family D (ALD), member 3 |
| chr17_+_27071002 | 4.52 |
ENST00000262395.5
ENST00000422344.1 ENST00000444415.3 ENST00000262396.6 |
TRAF4
|
TNF receptor-associated factor 4 |
| chr14_-_23446021 | 4.47 |
ENST00000553592.1
|
AJUBA
|
ajuba LIM protein |
| chr12_+_121416437 | 4.28 |
ENST00000402929.1
ENST00000535955.1 ENST00000538626.1 ENST00000543427.1 |
HNF1A
|
HNF1 homeobox A |
| chr22_+_25003606 | 4.17 |
ENST00000432867.1
|
GGT1
|
gamma-glutamyltransferase 1 |
| chr10_+_102106829 | 4.05 |
ENST00000370355.2
|
SCD
|
stearoyl-CoA desaturase (delta-9-desaturase) |
| chr16_-_57514277 | 4.01 |
ENST00000562008.1
ENST00000567214.1 |
DOK4
|
docking protein 4 |
| chr6_+_32146131 | 3.91 |
ENST00000375094.3
|
RNF5
|
ring finger protein 5, E3 ubiquitin protein ligase |
| chr1_-_24126892 | 3.86 |
ENST00000374497.3
ENST00000425913.1 |
GALE
|
UDP-galactose-4-epimerase |
| chr22_+_25003568 | 3.73 |
ENST00000447416.1
|
GGT1
|
gamma-glutamyltransferase 1 |
| chr11_-_8816375 | 3.61 |
ENST00000530580.1
|
ST5
|
suppression of tumorigenicity 5 |
| chr4_-_10023095 | 3.51 |
ENST00000264784.3
|
SLC2A9
|
solute carrier family 2 (facilitated glucose transporter), member 9 |
| chr19_+_10197463 | 3.50 |
ENST00000590378.1
ENST00000397881.3 |
C19orf66
|
chromosome 19 open reading frame 66 |
| chr1_+_94884023 | 3.46 |
ENST00000315713.5
|
ABCD3
|
ATP-binding cassette, sub-family D (ALD), member 3 |
| chr1_-_43751276 | 3.43 |
ENST00000423420.1
|
C1orf210
|
chromosome 1 open reading frame 210 |
| chr1_+_241695424 | 3.37 |
ENST00000366558.3
ENST00000366559.4 |
KMO
|
kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) |
| chr13_+_76334567 | 3.30 |
ENST00000321797.8
|
LMO7
|
LIM domain 7 |
| chr3_-_187009468 | 3.25 |
ENST00000425937.1
|
MASP1
|
mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) |
| chr1_+_100435315 | 3.24 |
ENST00000370155.3
ENST00000465289.1 |
SLC35A3
|
solute carrier family 35 (UDP-N-acetylglucosamine (UDP-GlcNAc) transporter), member A3 |
| chr8_-_128231299 | 3.14 |
ENST00000500112.1
|
CCAT1
|
colon cancer associated transcript 1 (non-protein coding) |
| chrX_+_118108571 | 3.11 |
ENST00000304778.7
|
LONRF3
|
LON peptidase N-terminal domain and ring finger 3 |
| chr5_+_133842243 | 3.09 |
ENST00000515627.2
|
AC005355.2
|
AC005355.2 |
| chr17_-_47786375 | 3.05 |
ENST00000511657.1
|
SLC35B1
|
solute carrier family 35, member B1 |
| chr6_+_43739697 | 3.00 |
ENST00000230480.6
|
VEGFA
|
vascular endothelial growth factor A |
| chr13_+_76334795 | 2.91 |
ENST00000526202.1
ENST00000465261.2 |
LMO7
|
LIM domain 7 |
| chr19_+_35630022 | 2.89 |
ENST00000589209.1
|
FXYD1
|
FXYD domain containing ion transport regulator 1 |
| chr7_-_47621229 | 2.80 |
ENST00000434451.1
|
TNS3
|
tensin 3 |
| chr7_+_192969 | 2.76 |
ENST00000313766.5
|
FAM20C
|
family with sequence similarity 20, member C |
| chr14_-_51561784 | 2.75 |
ENST00000360392.4
|
TRIM9
|
tripartite motif containing 9 |
| chr14_+_39735411 | 2.45 |
ENST00000603904.1
|
RP11-407N17.3
|
cTAGE family member 5 isoform 4 |
| chrX_+_118108601 | 2.45 |
ENST00000371628.3
|
LONRF3
|
LON peptidase N-terminal domain and ring finger 3 |
| chr17_-_2614927 | 2.42 |
ENST00000435359.1
|
CLUH
|
clustered mitochondria (cluA/CLU1) homolog |
| chr11_-_118550346 | 2.37 |
ENST00000530256.1
|
TREH
|
trehalase (brush-border membrane glycoprotein) |
| chr1_+_241695670 | 2.34 |
ENST00000366557.4
|
KMO
|
kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) |
| chr12_+_121163602 | 2.29 |
ENST00000411593.2
|
ACADS
|
acyl-CoA dehydrogenase, C-2 to C-3 short chain |
| chr12_-_51422017 | 2.25 |
ENST00000394904.3
|
SLC11A2
|
solute carrier family 11 (proton-coupled divalent metal ion transporter), member 2 |
| chr9_+_27109133 | 2.24 |
ENST00000519097.1
ENST00000380036.4 |
TEK
|
TEK tyrosine kinase, endothelial |
| chr12_+_121163538 | 2.22 |
ENST00000242592.4
|
ACADS
|
acyl-CoA dehydrogenase, C-2 to C-3 short chain |
| chr16_+_21244986 | 2.20 |
ENST00000311620.5
|
ANKS4B
|
ankyrin repeat and sterile alpha motif domain containing 4B |
| chr14_-_23446003 | 2.16 |
ENST00000553911.1
|
AJUBA
|
ajuba LIM protein |
| chr19_+_10196981 | 2.15 |
ENST00000591813.1
|
C19orf66
|
chromosome 19 open reading frame 66 |
| chr1_-_43751230 | 2.07 |
ENST00000523677.1
|
C1orf210
|
chromosome 1 open reading frame 210 |
| chr12_-_7125770 | 2.07 |
ENST00000261407.4
|
LPCAT3
|
lysophosphatidylcholine acyltransferase 3 |
| chr5_+_72469014 | 2.03 |
ENST00000296776.5
|
TMEM174
|
transmembrane protein 174 |
| chr19_-_10687983 | 1.98 |
ENST00000587069.1
|
AP1M2
|
adaptor-related protein complex 1, mu 2 subunit |
| chr13_+_50656307 | 1.97 |
ENST00000378180.4
|
DLEU1
|
deleted in lymphocytic leukemia 1 (non-protein coding) |
| chr13_-_28896641 | 1.92 |
ENST00000543394.1
|
FLT1
|
fms-related tyrosine kinase 1 |
| chr7_+_33765593 | 1.91 |
ENST00000311067.3
|
RP11-89N17.1
|
HCG1643653; Uncharacterized protein |
| chr17_+_4853442 | 1.90 |
ENST00000522301.1
|
ENO3
|
enolase 3 (beta, muscle) |
| chr2_+_219135115 | 1.89 |
ENST00000248451.3
ENST00000273077.4 |
PNKD
|
paroxysmal nonkinesigenic dyskinesia |
| chr13_+_76334498 | 1.83 |
ENST00000534657.1
|
LMO7
|
LIM domain 7 |
| chr20_+_36661910 | 1.82 |
ENST00000373433.4
|
RPRD1B
|
regulation of nuclear pre-mRNA domain containing 1B |
| chr9_-_27005686 | 1.82 |
ENST00000380055.5
|
LRRC19
|
leucine rich repeat containing 19 |
| chr12_+_56114189 | 1.79 |
ENST00000548082.1
|
RDH5
|
retinol dehydrogenase 5 (11-cis/9-cis) |
| chr15_-_63448973 | 1.78 |
ENST00000462430.1
|
RPS27L
|
ribosomal protein S27-like |
| chr9_-_71155783 | 1.76 |
ENST00000377311.3
|
TMEM252
|
transmembrane protein 252 |
| chr12_+_56114151 | 1.75 |
ENST00000547072.1
ENST00000552930.1 ENST00000257895.5 |
RDH5
|
retinol dehydrogenase 5 (11-cis/9-cis) |
| chr4_+_159593271 | 1.69 |
ENST00000512251.1
ENST00000511912.1 |
ETFDH
|
electron-transferring-flavoprotein dehydrogenase |
| chr17_-_17494972 | 1.67 |
ENST00000435340.2
ENST00000255389.5 ENST00000395781.2 |
PEMT
|
phosphatidylethanolamine N-methyltransferase |
| chr3_+_124303539 | 1.59 |
ENST00000428018.2
|
KALRN
|
kalirin, RhoGEF kinase |
| chr6_+_30881982 | 1.59 |
ENST00000321897.5
ENST00000416670.2 ENST00000542001.1 ENST00000428017.1 |
VARS2
|
valyl-tRNA synthetase 2, mitochondrial |
| chr14_-_39572279 | 1.58 |
ENST00000536508.1
|
SEC23A
|
Sec23 homolog A (S. cerevisiae) |
| chr7_+_100547156 | 1.54 |
ENST00000379458.4
|
MUC3A
|
Protein LOC100131514 |
| chr2_+_173724771 | 1.52 |
ENST00000538974.1
ENST00000540783.1 |
RAPGEF4
|
Rap guanine nucleotide exchange factor (GEF) 4 |
| chr8_-_79717163 | 1.48 |
ENST00000520269.1
|
IL7
|
interleukin 7 |
| chr19_+_35629702 | 1.48 |
ENST00000351325.4
|
FXYD1
|
FXYD domain containing ion transport regulator 1 |
| chr17_-_2615031 | 1.45 |
ENST00000576885.1
ENST00000574426.2 |
CLUH
|
clustered mitochondria (cluA/CLU1) homolog |
| chr15_-_41120896 | 1.41 |
ENST00000299174.5
ENST00000427255.2 |
PPP1R14D
|
protein phosphatase 1, regulatory (inhibitor) subunit 14D |
| chr12_+_53497263 | 1.34 |
ENST00000551896.1
ENST00000301466.3 |
SOAT2
|
sterol O-acyltransferase 2 |
| chr6_+_80341000 | 1.25 |
ENST00000369838.4
|
SH3BGRL2
|
SH3 domain binding glutamic acid-rich protein like 2 |
| chr16_+_81272287 | 1.25 |
ENST00000425577.2
ENST00000564552.1 |
BCMO1
|
beta-carotene 15,15'-monooxygenase 1 |
| chr9_-_116065551 | 1.22 |
ENST00000297894.5
|
RNF183
|
ring finger protein 183 |
| chr5_+_34757309 | 1.16 |
ENST00000397449.1
|
RAI14
|
retinoic acid induced 14 |
| chr11_+_119056178 | 1.15 |
ENST00000525131.1
ENST00000531114.1 ENST00000355547.5 ENST00000322712.4 |
PDZD3
|
PDZ domain containing 3 |
| chr6_+_30882108 | 1.13 |
ENST00000541562.1
ENST00000421263.1 |
VARS2
|
valyl-tRNA synthetase 2, mitochondrial |
| chr19_-_15235906 | 1.03 |
ENST00000600984.1
|
ILVBL
|
ilvB (bacterial acetolactate synthase)-like |
| chr19_-_49339080 | 1.03 |
ENST00000595764.1
|
HSD17B14
|
hydroxysteroid (17-beta) dehydrogenase 14 |
| chr18_-_61034743 | 1.02 |
ENST00000406396.3
|
KDSR
|
3-ketodihydrosphingosine reductase |
| chr19_+_4639514 | 1.01 |
ENST00000327473.4
|
TNFAIP8L1
|
tumor necrosis factor, alpha-induced protein 8-like 1 |
| chr1_+_113217345 | 0.98 |
ENST00000357443.2
|
MOV10
|
Mov10, Moloney leukemia virus 10, homolog (mouse) |
| chr18_-_54318353 | 0.93 |
ENST00000590954.1
ENST00000540155.1 |
TXNL1
|
thioredoxin-like 1 |
| chr1_+_113217043 | 0.92 |
ENST00000413052.2
|
MOV10
|
Mov10, Moloney leukemia virus 10, homolog (mouse) |
| chr1_+_180601139 | 0.90 |
ENST00000367590.4
ENST00000367589.3 |
XPR1
|
xenotropic and polytropic retrovirus receptor 1 |
| chr2_-_27603582 | 0.88 |
ENST00000323703.6
ENST00000436006.1 |
ZNF513
|
zinc finger protein 513 |
| chr2_-_62733476 | 0.88 |
ENST00000335390.5
|
TMEM17
|
transmembrane protein 17 |
| chr11_-_32456891 | 0.82 |
ENST00000452863.3
|
WT1
|
Wilms tumor 1 |
| chr8_+_96037205 | 0.80 |
ENST00000396124.4
|
NDUFAF6
|
NADH dehydrogenase (ubiquinone) complex I, assembly factor 6 |
| chr1_+_113217073 | 0.79 |
ENST00000369645.1
|
MOV10
|
Mov10, Moloney leukemia virus 10, homolog (mouse) |
| chr1_+_100435535 | 0.79 |
ENST00000427993.2
|
SLC35A3
|
solute carrier family 35 (UDP-N-acetylglucosamine (UDP-GlcNAc) transporter), member A3 |
| chr11_-_63536113 | 0.78 |
ENST00000433688.1
ENST00000546282.2 |
C11orf95
RP11-466C23.4
|
chromosome 11 open reading frame 95 RP11-466C23.4 |
| chr10_+_99349450 | 0.75 |
ENST00000370640.3
|
C10orf62
|
chromosome 10 open reading frame 62 |
| chr1_+_113217309 | 0.74 |
ENST00000544796.1
ENST00000369644.1 |
MOV10
|
Mov10, Moloney leukemia virus 10, homolog (mouse) |
| chr15_+_101142722 | 0.74 |
ENST00000332783.7
ENST00000558747.1 ENST00000343276.4 |
ASB7
|
ankyrin repeat and SOCS box containing 7 |
| chr2_+_120303717 | 0.73 |
ENST00000594371.1
|
PCDP1
|
Primary ciliary dyskinesia protein 1 |
| chr15_-_100273544 | 0.73 |
ENST00000409796.1
ENST00000545021.1 ENST00000344791.2 ENST00000332728.4 ENST00000450512.1 |
LYSMD4
|
LysM, putative peptidoglycan-binding, domain containing 4 |
| chr11_-_65381643 | 0.72 |
ENST00000309100.3
ENST00000529839.1 ENST00000526293.1 |
MAP3K11
|
mitogen-activated protein kinase kinase kinase 11 |
Network of associatons between targets according to the STRING database.
First level regulatory network of HNF4A
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 10.6 | 52.9 | GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) positive regulation of phospholipid catabolic process(GO:0060697) |
| 9.5 | 28.6 | GO:1901253 | negative regulation of intracellular transport of viral material(GO:1901253) |
| 9.0 | 62.9 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
| 8.7 | 34.7 | GO:0035565 | regulation of pronephros size(GO:0035565) |
| 7.2 | 21.7 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
| 5.6 | 16.7 | GO:2000910 | negative regulation of cholesterol import(GO:0060621) negative regulation of sterol import(GO:2000910) |
| 5.2 | 41.3 | GO:0034371 | chylomicron remodeling(GO:0034371) |
| 5.1 | 20.4 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
| 5.0 | 10.1 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
| 4.7 | 23.7 | GO:0002933 | lipid hydroxylation(GO:0002933) |
| 4.3 | 12.8 | GO:0070781 | arginine biosynthetic process via ornithine(GO:0042450) response to biotin(GO:0070781) |
| 3.8 | 30.0 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
| 3.7 | 11.2 | GO:0097187 | dentinogenesis(GO:0097187) |
| 3.3 | 13.2 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
| 3.2 | 9.5 | GO:1901053 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 2.4 | 42.8 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
| 2.3 | 51.5 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
| 2.3 | 16.0 | GO:0046440 | L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
| 2.2 | 17.7 | GO:0009441 | glycolate metabolic process(GO:0009441) |
| 2.2 | 2.2 | GO:1904106 | protein localization to microvillus(GO:1904106) |
| 2.1 | 19.0 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
| 2.0 | 6.1 | GO:0045720 | negative regulation of integrin biosynthetic process(GO:0045720) |
| 2.0 | 18.2 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 2.0 | 8.1 | GO:0031456 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 1.9 | 5.8 | GO:0060061 | Spemann organizer formation(GO:0060061) |
| 1.9 | 9.7 | GO:0061528 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
| 1.9 | 15.0 | GO:0015811 | L-cystine transport(GO:0015811) |
| 1.7 | 37.7 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 1.6 | 6.3 | GO:0046110 | xanthine metabolic process(GO:0046110) |
| 1.5 | 18.6 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 1.5 | 7.5 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
| 1.4 | 9.8 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
| 1.4 | 9.6 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
| 1.3 | 4.0 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 1.3 | 26.3 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 1.2 | 13.2 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
| 1.1 | 5.6 | GO:0038169 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 1.1 | 17.2 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 1.1 | 17.0 | GO:0015747 | urate transport(GO:0015747) |
| 1.0 | 3.0 | GO:1903572 | regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
| 1.0 | 7.8 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
| 0.9 | 9.3 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.9 | 8.1 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
| 0.9 | 6.2 | GO:0008295 | spermidine biosynthetic process(GO:0008295) primary amino compound biosynthetic process(GO:1901162) |
| 0.8 | 8.5 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
| 0.8 | 32.3 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
| 0.8 | 4.0 | GO:1990569 | UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
| 0.8 | 3.1 | GO:0015785 | UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
| 0.7 | 2.8 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
| 0.7 | 8.7 | GO:0045329 | amino-acid betaine biosynthetic process(GO:0006578) carnitine biosynthetic process(GO:0045329) |
| 0.6 | 1.9 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.6 | 8.1 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
| 0.6 | 8.6 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
| 0.6 | 19.7 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.5 | 4.4 | GO:0010734 | protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
| 0.5 | 6.6 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 0.5 | 2.7 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
| 0.4 | 16.3 | GO:0015879 | carnitine transport(GO:0015879) |
| 0.4 | 2.2 | GO:0015692 | lead ion transport(GO:0015692) |
| 0.3 | 11.0 | GO:0034389 | lipid particle organization(GO:0034389) |
| 0.3 | 3.4 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.3 | 13.2 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.3 | 1.8 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.3 | 4.5 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
| 0.3 | 2.2 | GO:0048014 | Tie signaling pathway(GO:0048014) |
| 0.3 | 7.5 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.3 | 15.3 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
| 0.3 | 3.5 | GO:0046415 | urate metabolic process(GO:0046415) |
| 0.2 | 23.7 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.2 | 32.1 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
| 0.2 | 3.9 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.2 | 27.3 | GO:0030449 | regulation of complement activation(GO:0030449) |
| 0.2 | 0.8 | GO:0072302 | negative regulation of metanephric glomerulus development(GO:0072299) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) |
| 0.2 | 5.2 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.2 | 3.9 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.2 | 1.7 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.1 | 2.8 | GO:0048286 | lung alveolus development(GO:0048286) |
| 0.1 | 11.9 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
| 0.1 | 0.6 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.1 | 2.4 | GO:0005984 | disaccharide metabolic process(GO:0005984) oligosaccharide catabolic process(GO:0009313) |
| 0.1 | 0.5 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
| 0.1 | 0.9 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
| 0.1 | 5.6 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
| 0.1 | 0.9 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.1 | 1.9 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 0.1 | 1.7 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.1 | 1.7 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.1 | 1.3 | GO:0034433 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
| 0.1 | 0.9 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.1 | 4.5 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
| 0.1 | 0.7 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.1 | 1.8 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 0.1 | 0.2 | GO:0048203 | vesicle targeting, trans-Golgi to endosome(GO:0048203) |
| 0.1 | 3.5 | GO:0042572 | retinol metabolic process(GO:0042572) |
| 0.1 | 1.0 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
| 0.1 | 2.1 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
| 0.1 | 0.5 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
| 0.1 | 1.0 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 0.0 | 1.0 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
| 0.0 | 0.2 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
| 0.0 | 5.6 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
| 0.0 | 1.9 | GO:0006735 | NADH regeneration(GO:0006735) glycolytic process through fructose-6-phosphate(GO:0061615) glycolytic process through glucose-6-phosphate(GO:0061620) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 0.0 | 0.4 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
| 0.0 | 1.5 | GO:0002360 | T cell lineage commitment(GO:0002360) |
| 0.0 | 0.1 | GO:1900535 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.0 | 1.8 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.0 | 0.9 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.0 | 0.4 | GO:0060395 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) SMAD protein signal transduction(GO:0060395) |
| 0.0 | 0.3 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
| 0.0 | 9.0 | GO:0000209 | protein polyubiquitination(GO:0000209) |
| 0.0 | 0.1 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
| 0.0 | 11.0 | GO:0042493 | response to drug(GO:0042493) |
| 0.0 | 1.1 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
| 0.0 | 0.4 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 8.2 | 73.9 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
| 3.8 | 37.7 | GO:0005579 | membrane attack complex(GO:0005579) |
| 1.9 | 9.7 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
| 1.9 | 37.0 | GO:0042627 | chylomicron(GO:0042627) |
| 0.7 | 55.9 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.7 | 9.6 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.5 | 8.6 | GO:0032426 | stereocilium tip(GO:0032426) |
| 0.5 | 16.3 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.4 | 5.8 | GO:1990909 | Wnt signalosome(GO:1990909) |
| 0.4 | 2.2 | GO:0070826 | paraferritin complex(GO:0070826) |
| 0.4 | 9.3 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.3 | 7.8 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
| 0.2 | 21.5 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.2 | 6.3 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
| 0.2 | 56.5 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.2 | 1.9 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.2 | 3.9 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
| 0.2 | 1.7 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 0.2 | 4.4 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 0.1 | 0.4 | GO:0032302 | MutSbeta complex(GO:0032302) |
| 0.1 | 227.0 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
| 0.1 | 11.0 | GO:0005811 | lipid particle(GO:0005811) |
| 0.1 | 8.8 | GO:0005902 | microvillus(GO:0005902) |
| 0.1 | 11.9 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
| 0.1 | 2.4 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.1 | 26.7 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
| 0.1 | 46.3 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 0.0 | 4.6 | GO:0005871 | kinesin complex(GO:0005871) |
| 0.0 | 9.4 | GO:0009986 | cell surface(GO:0009986) |
| 0.0 | 0.9 | GO:0036038 | MKS complex(GO:0036038) |
| 0.0 | 8.7 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
| 0.0 | 17.6 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.0 | 9.0 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
| 0.0 | 0.4 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
| 0.0 | 3.9 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.0 | 2.1 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 0.0 | 5.5 | GO:0055037 | recycling endosome(GO:0055037) |
| 0.0 | 5.3 | GO:0043296 | apical junction complex(GO:0043296) |
| 0.0 | 9.3 | GO:0005667 | transcription factor complex(GO:0005667) |
| 0.0 | 0.5 | GO:0060077 | inhibitory synapse(GO:0060077) |
| 0.0 | 2.8 | GO:0030425 | dendrite(GO:0030425) |
| 0.0 | 1.1 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
| 0.0 | 74.5 | GO:0070062 | extracellular exosome(GO:0070062) |
| 0.0 | 8.0 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
| 0.0 | 0.3 | GO:0030057 | desmosome(GO:0030057) |
| 0.0 | 26.6 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
| 0.0 | 0.8 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
| 0.0 | 3.0 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 10.5 | 52.4 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
| 7.6 | 52.9 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
| 6.8 | 20.4 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
| 6.4 | 38.2 | GO:0004882 | androgen receptor activity(GO:0004882) |
| 5.9 | 17.7 | GO:0052852 | (S)-2-hydroxy-acid oxidase activity(GO:0003973) very-long-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052852) long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity(GO:0052853) medium-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052854) |
| 5.0 | 30.0 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
| 4.6 | 18.6 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
| 4.6 | 37.0 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
| 3.6 | 75.3 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
| 3.5 | 20.9 | GO:0035473 | lipase binding(GO:0035473) |
| 3.2 | 9.5 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
| 3.1 | 21.7 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
| 2.8 | 28.2 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 2.7 | 16.0 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
| 2.6 | 23.7 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
| 2.4 | 9.8 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
| 2.2 | 8.7 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
| 2.0 | 16.3 | GO:0005124 | scavenger receptor binding(GO:0005124) |
| 1.9 | 9.7 | GO:0047298 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
| 1.9 | 13.2 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
| 1.9 | 13.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
| 1.9 | 15.0 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
| 1.7 | 52.2 | GO:0001848 | complement binding(GO:0001848) |
| 1.7 | 12.0 | GO:0016936 | galactoside binding(GO:0016936) |
| 1.6 | 8.0 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
| 1.5 | 7.5 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
| 1.5 | 20.8 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
| 1.3 | 30.8 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
| 1.2 | 20.5 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
| 1.1 | 5.6 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 1.0 | 3.9 | GO:0003978 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
| 0.9 | 11.9 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
| 0.9 | 32.3 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
| 0.8 | 4.0 | GO:0005462 | UDP-N-acetylglucosamine transmembrane transporter activity(GO:0005462) |
| 0.8 | 3.1 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
| 0.7 | 13.2 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
| 0.7 | 8.5 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
| 0.7 | 6.3 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
| 0.6 | 1.9 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
| 0.6 | 8.5 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
| 0.6 | 23.6 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
| 0.6 | 12.8 | GO:0042301 | phosphate ion binding(GO:0042301) |
| 0.6 | 8.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.6 | 10.9 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
| 0.6 | 1.7 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
| 0.6 | 1.7 | GO:0000773 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
| 0.5 | 3.0 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
| 0.5 | 15.8 | GO:0071949 | FAD binding(GO:0071949) |
| 0.5 | 2.7 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
| 0.4 | 4.0 | GO:0016215 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
| 0.4 | 1.3 | GO:0034736 | sterol O-acyltransferase activity(GO:0004772) cholesterol O-acyltransferase activity(GO:0034736) |
| 0.4 | 2.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 0.4 | 6.2 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
| 0.4 | 2.2 | GO:0015094 | cadmium ion transmembrane transporter activity(GO:0015086) cobalt ion transmembrane transporter activity(GO:0015087) lead ion transmembrane transporter activity(GO:0015094) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
| 0.3 | 5.3 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.3 | 12.0 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.3 | 4.5 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.3 | 6.6 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.2 | 4.5 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
| 0.2 | 0.9 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 0.2 | 1.9 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.2 | 0.7 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 0.2 | 3.9 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.2 | 0.8 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
| 0.2 | 7.5 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
| 0.1 | 1.0 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
| 0.1 | 0.4 | GO:0000406 | double-strand/single-strand DNA junction binding(GO:0000406) dinucleotide repeat insertion binding(GO:0032181) |
| 0.1 | 9.3 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.1 | 14.8 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
| 0.1 | 3.5 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
| 0.1 | 0.6 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.1 | 1.1 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
| 0.1 | 3.2 | GO:0048018 | receptor agonist activity(GO:0048018) |
| 0.1 | 1.9 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
| 0.1 | 22.6 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
| 0.1 | 5.6 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.1 | 8.1 | GO:0050660 | flavin adenine dinucleotide binding(GO:0050660) |
| 0.1 | 0.5 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
| 0.1 | 0.9 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
| 0.1 | 1.0 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
| 0.1 | 13.6 | GO:0005319 | lipid transporter activity(GO:0005319) |
| 0.1 | 1.8 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
| 0.1 | 9.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.1 | 4.0 | GO:0005158 | insulin receptor binding(GO:0005158) |
| 0.1 | 0.3 | GO:0051870 | methotrexate binding(GO:0051870) |
| 0.1 | 4.4 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.1 | 0.2 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
| 0.0 | 12.7 | GO:0008168 | methyltransferase activity(GO:0008168) |
| 0.0 | 4.6 | GO:0003777 | microtubule motor activity(GO:0003777) |
| 0.0 | 2.8 | GO:0030145 | manganese ion binding(GO:0030145) |
| 0.0 | 13.7 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
| 0.0 | 0.8 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
| 0.0 | 2.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.0 | 6.2 | GO:0017124 | SH3 domain binding(GO:0017124) |
| 0.0 | 1.5 | GO:0030552 | cAMP binding(GO:0030552) |
| 0.0 | 7.8 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.0 | 0.9 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.0 | 11.9 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
| 0.0 | 2.4 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
| 0.0 | 0.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.0 | 0.1 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.4 | 124.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.6 | 59.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.2 | 4.9 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.2 | 32.1 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
| 0.1 | 5.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.1 | 53.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.1 | 3.5 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.1 | 15.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.1 | 5.0 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.0 | 2.2 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.0 | 3.3 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 0.0 | 1.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.0 | 0.9 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
| 0.0 | 2.2 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.0 | 0.7 | PID IFNG PATHWAY | IFN-gamma pathway |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 7.2 | 129.8 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
| 3.0 | 90.6 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 1.7 | 45.5 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
| 1.4 | 20.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 1.2 | 21.7 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
| 1.2 | 50.2 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
| 1.2 | 37.7 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
| 1.1 | 20.4 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
| 1.1 | 22.6 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
| 1.1 | 27.3 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.8 | 16.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
| 0.7 | 20.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.6 | 6.3 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.5 | 11.0 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.5 | 13.2 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.4 | 10.9 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
| 0.3 | 5.3 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.3 | 34.5 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.3 | 18.6 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
| 0.3 | 13.2 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.2 | 9.7 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
| 0.2 | 6.2 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
| 0.2 | 4.5 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.2 | 4.9 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.2 | 15.0 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
| 0.2 | 59.9 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
| 0.2 | 5.0 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
| 0.2 | 8.2 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
| 0.1 | 2.4 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
| 0.1 | 3.5 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.1 | 4.0 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.1 | 3.4 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
| 0.1 | 8.1 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.1 | 2.1 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
| 0.1 | 5.1 | REACTOME KINESINS | Genes involved in Kinesins |
| 0.1 | 13.9 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
| 0.1 | 8.9 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.1 | 13.3 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.1 | 2.7 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 0.1 | 8.5 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.1 | 1.7 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| 0.1 | 1.1 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.1 | 2.3 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.0 | 1.5 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.0 | 1.7 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
| 0.0 | 1.5 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
| 0.0 | 4.4 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 0.0 | 3.9 | REACTOME METABOLISM OF CARBOHYDRATES | Genes involved in Metabolism of carbohydrates |
| 0.0 | 1.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.0 | 0.4 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.0 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
| 0.0 | 3.1 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
| 0.0 | 3.1 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |